ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1420 • ACR Convergence 2025

    A Nationwide Analysis of In-Hospital Mortality in Adult Ankylosing Spondylitis

    Isadora Small1, Anuya Natu2 and Augustine Manadan3, 1The Latin School of Chicago, Chicago, IL, 2John H Stroger, Jr. Hospital of Cook County, Chicago, IL, 3Rush University Medical Center, Chicago, IL

    Background/Purpose: Ankylosing spondylitis (AS) is a chronic inflammatory disease with systemic complications that may contribute to increased mortality risk. This study examines the characteristics and…
  • Abstract Number: 1414 • ACR Convergence 2025

    Multidimensional Assessment to Differentiate Early Psoriatic Arthritis from Cutaneous Psoriasis

    Eugeniu Russu1, Victor Cazac2, Mircea Betiu3, Alesea Nistor3 and Liliana Groppa4, 1"Nicolae Testemitanu" State Medical and Pharmaceutical University; ”Timofei Moșneaga” Republican Clinical Hospital, Chisinau, Moldova, 2Norwalk Hospital, Nuvance Health, Connecticut, 3State Medical and Pharmaceutical University ”Nicolae Testemițanu”, Chisinau, Chisinau, Moldova, 4State Medical and Pharmaceutical University ”Nicolae Testemițanu”, Chisinau, Moldova

    Background/Purpose: Psoriatic arthritis (PsA) develops in ~20-30% of psoriasis patients. However, early PsA diagnosis is challenging due to heterogeneous, subtle symptoms and overlap with psoriasis…
  • Abstract Number: 1365 • ACR Convergence 2025

    Economic impact of early treatment and strict disease control in rheumatoid arthritis: a cost-minimization approach concerning biological therapy

    Raianni Rúbia Pacheco Silva1, Daniel da Silva Pereira Curado2, Paula Cristina Montina2, Everton Nunes da Silva3, Ana Paula Monteiro Gomides2, Rina Dalva Neubarth Giorgi4, Leticia Rocha Pereira5, Sebastião Cezar Radominski6, Ivanio Alves Pereira7, Maria Fernanda Brandão de Resende Guimarães8, Manoel Barros Bertolo9, Paulo Louzada Junior10, Maria de Fátima Lobato da Cunha Sauma11, Karina Rossi Bonfiglioli5, Claiton Viegas Brenol12, Geraldo da Rocha Castelar Pinheiro13, Cleandro Pires de Albuquerque2 and Licia Maria Henrique da Mota14, 1Universidade de Brasília, Brasília, Distrito Federal, Brazil, 2Universidade de Brasília, Brasília, Brazil, 3Universidade de Brasília, brasilia, Brazil, 4IAMSPE, São Paulo, Brazil, 5Hospital do Servidor Público Estadual de São Paulo, São Paulo, Brazil, 6UFPR, Curitiba, Brazil, 7UFSC, Florianopolis, Brazil, 8UFMG, Belo Horizonte, Brazil, 9Unicamp, Campinas, Brazil, 10USP-RP, Ribeirão Preto, Brazil, 11UFPA, Belem, Brazil, 12UFRGS, Porto Alegre, Brazil, 13UERJ, Rio de Janeiro, Brazil, 14UNB, Brasilia, Distrito Federal, Brazil

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic, progressive, potentially disabling autoimmune disease, with substantial economic burden, particularly related to its high-cost pharmacological treatment. Early treatment,…
  • Abstract Number: 1350 • ACR Convergence 2025

    Initial Biologic Therapy Improves Sexual Function in Female Patients with Rheumatoid Arthritis: A 6 Month Follow-Up Study

    Daniel Zavada1, Barbora Vala2, Adela Navratilova2, Veronika Losterova2, Lenka Moravcova2, Jiri Vencovsky3, Ladislav Šenolt4, Karel Pavelka5 and Michal Tomcik5, 1Institute of Rheumatology, Prague; Charles University, Third Faculty of Medicine, Hlavné mesto Praha, Czech Republic, 2Institute of Rheumatology, Praha, Czech Republic, 3Institute of Rheumatology, Praha 8, Czech Republic, 4Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 5Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic

    Background/Purpose: Rheumatoid arthritis (RA) significantly impacts quality of life in multiple domains. This study aimed to evaluate the impact of initial biologic/targeted synthetic disease-modifying anti-rheumatic…
  • Abstract Number: 1318 • ACR Convergence 2025

    Diagnostic Delay in Rheumatoid Arthritis and its Impact on Radiographic Outcomes: A Systematic Review and Meta-analysis of 100,066 Patients

    Mohamed Abdelsalam1, Menat Alla Ayman Ali Mahdy2, Bassant Elaraby Elsayed Badwy2, Maryam Lasheen3, Omar Sameh Nabil El Sedafy1, Hadeer Hafez4 and Mohamed Reda Awad5, 1Misr University For Science and Technology, 6 october, Al Jizah, Egypt, 2Misr University For Science and Technology, Nasr City, Al Qahirah, Egypt, 3Misr University For Science and Technology, Helwan, Al Qahirah, Egypt, 46th October University, 6 october, Al Jizah, Egypt, 5Al Azhar University, Cairo, Egypt, Giza, Al Jizah, Egypt

    Background/Purpose: Timely diagnosis is the cornerstone of effective rheumatoid arthritis (RA) management, with early treatment shown to significantly improve outcomes through a treat-to-target strategy. While…
  • Abstract Number: 1400 • ACR Convergence 2025

    Beyond the Glands: Hypogammaglobulinemia as a Clue to Peripheral Neuropathy in Sjogren´s Disease

    Renata Fróes Ramos de Lima1, Regis Sewa Marques2, Zoraida Sachetto3 and Alisson Pugliesi4, 1Universidade Estadual de Campinas (UNICAMP), Campinas, Sao Paulo, Brazil, 2Universidade Estadual de Campinas, Campinas, Sao Paulo, Brazil, 3UNIVERSIDADE ESTADUAL DE CAMPINAS, UNICAMP, Campinas, Sao Paulo, Brazil, 4Unicamp, Campinas, Brazil

    Background/Purpose: Sjogren’s disease (SjD) is a systemic autoimmune disorder characterized by inflammatory involvement of the exocrine glands and extra-glandular manifestations. Among the latter, there is…
  • Abstract Number: 1362 • ACR Convergence 2025

    Multimodal Spatial and Single-Cell Profiling of Synovial Tissue Reveals Macrophage Programs Associated with Biologic TherapyTreatment Response in Rheumatoid Arthritis

    Mohammad Daud Khan1, Matthew Dapas2, Salina T Dominguez1, Tyler Therron3, Kathleen Aren4, Mary Carns5, Hadijat Makinde5, Arthur M Mandelin1, Eric M Ruderman1, John F Seagrist5, Ruth Misha1, Carla Marie Cuda5, Harris R Perlman5 and Deborah Rachelle Winter6, 1Northwestern University, Chicago, 2Northwestern University Feinberg School of Medicine, Chicago, IL, 3Northwestern Feinberg School of Medicine, Chicago, IL, 4Northwestern University Division of Rheumatology, Chicago, IL, 5Northwestern University, Chicago, IL, 6Northwestern University, Skokie, IL

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disease driven by persistent synovial inflammation and progressive joint damage. Selecting an effective biologic therapy remains a…
  • Abstract Number: 1281 • ACR Convergence 2025

    Ethnic Disparities in Mental Health Screening, Diagnoses, and Outcomes in Patients with Childhood-Onset Systemic Lupus Erythematosus

    Alicia Tran1, Indrani Das2, Zhaoyu Ding3, Daniela Dominguez4, Sefi Kronenberg5, Lawrence Ng6, Alene Toulany1, Gwyneth Zai7, Deborah Levy1, Andrea Knight8 and Linda Hiraki1, 1The Hospital for Sick Children, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3SickKids Research Institute, Toronto, ON, Canada, 4The Hospital for Sick Children, Toronto, Canada, 5Holland Bloorview Kids Rehabilitation Hospital, Toronto, ON, Canada, 6The Hospital for Sick Children, Toronto, Canada, Toronto, ON, Canada, 7Centre for Addiction & Mental Health, Toronto, ON, Canada, 8Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: Patients with childhood-onset systemic lupus erythematosus (cSLE) face higher risks of depression and anxiety compared to healthy peers. In 2022, standardized mental health (MH)…
  • Abstract Number: 1409 • ACR Convergence 2025

    The impact of depression in axial spondyloarthritis: Epidemiological insights from the Ankylosing Spondylitis Registry of Ireland (ASRI)

    Conall Mac Gearailt1, Rebecca O'Farrell2, Mohamed Eltahir3, Brian Hallahan3, Andrew Smyth4, Finbar O'Shea5 and Gillian Fitzgerald3, 1Galway University Hospital, Galway, Galway, Ireland, 2Sligo University Hospital, Sligo, Ireland, 3Galway University Hospital, Galway, Ireland, 4University of Galway, Galway, Ireland, 5St James's Hospital and Trinity College Dublin, Dublin, Dublin, Ireland

    Background/Purpose: The burden of comorbidities in Axial Spondyloarthritis (axSpA) is increasingly recognised and contributes to the concept of difficult-to-treat axSpA (D2T-axSpA). The need to assess…
  • Abstract Number: 1320 • ACR Convergence 2025

    Trends In Incidence and Risk factors For Incident Venous Thromboembolism in Patients with Rheumatoid Arthritis: A Population-Based Retrospective Cohort Study

    Noah Frechette1, Elena myasoedova1, Iqra Javed1, Roslin George1, Sara Achenbach2 and Cynthia Crowson3, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, 3Mayo Clinic, Stewartvillle, MN

    Background/Purpose: Venous thromboembolism (VTE) is more common in patients with rheumatoid arthritis (RA) and can present as deep vein thrombosis (DVT) or pulmonary embolism (PE).…
  • Abstract Number: 1386 • ACR Convergence 2025

    Characterization and Progression of Localized Amyloidosis in Sjogren’s Syndrome: Evidence Long-Term (1995-2025) Follow-Up of a Cohort compared to Literature Review.

    Hoang Nguyen1, Philip Moresco2, Antoine Chiu2, Asha Patnaik3 and Peter Gorevic4, 1Stony Brook University-Renaissance School of Medicine- Department of Rheumatology, Jamaica, NY, 2Stony Brook University -Renaissance School of Medicine, Stony Brook, NY, 3Stony Brook University Hospital, Stony Brook, NY, 4Stony Brook University, Stony Brook, NY

    Background/Purpose: -Sjogren’s syndrome (SS) is a chronic autoimmune disorder, defined by keratoconjunctivitis sicca (KCS), specific serologies, and a significant risk of extra-exocrine disease manifestations and…
  • Abstract Number: 1262 • ACR Convergence 2025

    Perspectives of Lupus Patients on Quality of Life Measures: A Qualitative Study

    Cristina Arriens1, Fredonna Carthen2, Alexandre Cammarata-Mouchtouris1, Judith James1, Joan Merrill3 and Motolani Ogunsanya4, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Oklahoma Medical Research Foundation, Oklahoma, OK, 3Oklahoma Medical Research Foundation, Oklahoma City 73104, OK, 4University of Oklahoma Health Sciences Center, Edmond, OK

    Background/Purpose: Lupus has profound impact on physical, social, and emotional well-being. Health-related quality of life (HRQOL) measures are increasingly incorporated into lupus research and the…
  • Abstract Number: 1415 • ACR Convergence 2025

    The Association of Handedness with Radiographic Damage in Patients with Psoriatic Arthritis

    Fadi Kharouf1, Shahad Al-Matar2, Virginia Carrizo Abarza3, Pankti Mehta4, Shangyi Gao5, Daniel Pereira6, Richard Cook7, Vinod Chandran8, Denis Poddubnyy9 and Dafna D. Gladman10, 1University Health Network and University of Toronto, Toronto, ON, Canada, Toronto, ON, Canada, 2University of alberta, Edmonton, AB, Canada, 3Toronto Western Hospital - University of Toronto, Toronto, ON, Canada, 4University of Toronto, Gladman Krembil Psoriatic Arthritis Research Program, Toronto, ON, Canada, 5Gladman-Krembil Psoriatic Arthritis Research Program, Centre for Prognosis Studies in the Rheumatic Diseases, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada, Toronto, ON, Canada, 6University Health Network, Toronto, ON, Canada, 7University of Waterloo, Waterloo, Canada, 8University of Toronto, Toronto, ON, Canada, 9Division of Rheumatology, Department of Medicine, University Health Network and University of Toronto, Toronto, Ontario, Canada, and Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité – Universitätsmedizin Berlin, Berlin, Germany; Department of Epidemiology, German Rheumatism Research Centre, Berlin, Germany, 10Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, Division of Rheumatology, Toronto, ON, Canada

    Background/Purpose: Mechanical stress is known to trigger and exacerbate psoriatic arthritis (PsA). Based on the hypothesis that biomechanical stress is greater in the dominant extremity,…
  • Abstract Number: 1291 • ACR Convergence 2025

    Gastrointestinal Tract Involvement in Juvenile Systemic Sclerosis: Results from an International Scoping Review of Outcome Measures

    Lauren Robinson1, Lusine Ambartsumyan2, Emily Willis3, Aybuke Gunalp4, Simone Appenzeller5, Ozgur Kasapcopur6, Sarah Ishaq7, Natalia Vasquez Canizares8 and Suzanne Li9, 1Hospital for Special Surgery, New York, NY, 2Seattle Children's Hospital, Seattle, WA, 3Royal Manchester Children's Hospital, Manchester, United Kingdom, 4Cerrahpasa Medicine School, Cerrahpasa, Istanbul, Turkey, 5Unicamp, Campinas, São Paulo, Brazil, 6Istanbul University-Cerrahpasa, Cerrahpasa Medical School, istanbul, Turkey, 7Osteopathic Medicine , Touro College of Osteopathic Medicine, New York, NY, 8Children's Hospital at Montefiore, New York, NY, 9Joseph M. Sanzari Children's Hospital and Hackensack Meridian School of Medicine, Hackensack, NJ

    Background/Purpose: Gastrointestinal (GI) tract involvement is nearly universal in patients with systemic sclerosis (SSc) leading to significant morbidity and mortality. In a North American juvenile…
  • Abstract Number: 1418 • ACR Convergence 2025

    Impact of Type 2 Diabetes Mellitus on Cardiovascular Outcomes in Patients with Ankylosing Spondylitis on NSAID Therapy

    Godbless Ajenaghughrure1, Sila Mateo Faxas2, Gurjot Singh3, Nirys Mateo Faxas4, Kim Nguyen3, Nicole Tejeda5 and Kimberly Ramirez Bonetti6, 1Trihealth Good Samaritan Hospital, Cincinnati, OH, 2Good Samaritan Hospital, Cincinnati, OH, 3Trihealth Good Samaritan Hospital, Cincinnati, 4Independent Author, Santo Domingo, Dominican Republic, 5Independent Author, Cincinnati, 6Independent Author, cincinnati, OH

    Background/Purpose: Patients with ankylosing spondylitis (AS) have increased cardiovascular risk, potentially exacerbated by NSAID therapy. However, the additional impact of Type 2 diabetes mellitus (T2DM)…
  • « Previous Page
  • 1
  • …
  • 112
  • 113
  • 114
  • 115
  • 116
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology